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1. Introduction 
Globally, the proportion of elderly people is growing faster than any other age group. In 
2000, one in ten, or about 600 million, people were 60 years or older. By 2025, it is expected 
to reach 1.2 billion people, and in 2050 around 1.9 billion (Hutton, 2008). Aging is a multi-
factorial process and has been defined as a time-dependent general decline in physiological 
function of an organism associated with a progressively increasing risk of morbidity and 
mortality. It is apparent that during aging different organs are losing their functional reserve 
and plasticity and become less able to fulfill their physiological function, especially under 
conditions of stress (Beneke & Bürkle, 2007).  
Coronary heart disease is the leading cause of death worldwide, and 3.8 million men and 3.4 
million women die of the disease each year (Yellon & Hausenloy, 2007). Heart aging is 
accompanied by changes that are progressive, pervasive, potentially deleterious, and, as far 
as is known, irreversible (Juhaszova et al., 2005). The incidence of heart disease begins to 
increase in men after the age of forty-five and in women after the age of fifty-five, and the 
rate for women tends to equal that of men after the age of seventy (MacDonald, 2002). 
Regardless of age, the heart’s well-being is critically dependent on its blood supply, and 
vascular disease places this in jeopardy. With increasing age, narrowing may develop in the 
coronary arteries, which lead to the heart. Reduced blood supply causes ischemia 
(insufficient blood supply for the heart's work) and may produce chest pain or angina. If 
ischemia is prolonged, irreversible damage resulting in widespread cell death appears, 
leading to loss of contractility and impairment of cardiac pump function.  
Several studies have identified age as a strong predictor of adverse events after acute 
coronary syndromes; as a result, elderly persons are a high-risk subgroup. Mortality due to 
ischemic cardiovascular diseases is significantly higher in the elderly than in young adults. 
The average age for a first MI is 66 years in men and 70 years in women, nearly 50% of 
hospital admissions for acute MI and 80% who die are age 65 years and over (Jugdutt et al., 
2008, as cited in Ertl &Frantz, 2005; Cheitlin & Zipes, 2001; Thom et al., 2006). After an acute 
myocardial infarction, early and successful myocardial reperfusion with the use of 
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thrombolytic therapy or primary percutaneous coronary intervention (PCI) is the most 
effective strategy for reducing the size of a myocardial infarct and improving the clinical 
outcome. The process of restoring blood flow to the ischemic myocardium, however, can 
induce injury. This phenomenon is termed myocardial ischemia/reperfusion (MI/R) injury. 
This form of myocardial injury, which by itself can induce cardiomyocyte death and 
increase infarct size, may in part explain why, despite optimal myocardial reperfusion, the 
rate of death after an acute myocardial infarction approaches 10% and the incidence of 
cardiac failure after an acute myocardial infarction is almost 25% (Yellon & Hausenloy, 2007, 
as cited in Keeley, 2003).  
Cell death is a primary factor in the pathogenesis of infarction after I/R and, because 
survival is strongly correlated to the cardiac myocytes mass lost after I/R injury, can be 
induced by two different pathways, necrosis and apoptosis which coexist during I/R. 
Apoptosis is more prevalent than necrosis in senescent animals and humans and increased 
more significantly in old rats than in young adult ones after renal ischemia reperfusion. 
Different from necrosis, which is induced by injurious agents, apoptosis is an active 
programmed cell death characterized by a series of stereotypic morphological and 
biochemical features. Therefore, it is easier to inhibit apoptosis than to prohibit necrosis for 
the aging heart. Inhibition of apoptosis may confer protection. So, apoptosis would be one of 
the efficient targets to ameliorate more serious MI/R injury in aging. In this chapter we 
focus on aging-induced cardiac myocyte apoptosis and its potential mechanisms after I/R 
injury. The chapter is divided into 4 sections: (1)High sensitivity to ischemic heart disease in 
elderly people; (2) Aging increases myocardial apoptosis under basal and stressed 
conditions; (3) RNS signaling induced apoptosis contributes to increased susceptibility of 
aging hearts to myocardial ischemic injury; (4) A mitochondrial pro-apoptotic protein, 
HtrA2/Omi, is another reason for enhanced MI/R injury in the aging heart. 
2. High sensitivity to ischemic heart disease in the elderly 
2.1 Risk factors for ischemic heart disease 
Ischemic heart disease (IHD), defined as the earliest manifestation of myocardial infarction, 
stable or unstable angina pectoris or sudden death, is a vital problem in our society and 
remains to be a major cause of morbidity and mortality in the elderly. Consequently, the 
identification of factors related to IHD and quantification of levels of risk is increasingly 
popular. There are many risk factors contributing to IHD, ranging from blood pressure, both 
systolic blood pressure (SBP) and diastolic blood pressure (DBP), to living habits like 
smoking and excessive fat in take. These are undoubtedly the predictors of long term 
coronary heart disease. IHD, or myocardial ischemic injury, results from severe impairment 
of the coronary blood supply usually produced by thrombosis or other acute alterations of 
coronary atherosclerotic plaques resulting from these risk factors.  
Curiously, however, the question was raised if these risk factors for IHD found at a young 
age are still predictive at older ages because IHD may develop in men at a young, middle, or 
older age. Via long-term studies concerning changing effects of risk factors with age, it has 
been confirmed (Mathewson et al.,1960; Robert et al.,1998) that blood pressure up to age 65 
years manifested itself as a significant factor for IHD—for one thing, the benefit of 10mmHg 
lower blood pressure was smaller in older compared to younger men; smoking relevance is 
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higher for younger men than for older men; more interesting, the role of either BMI (Body 
Mass Index) or DM (Diabetes Mellitus) does not vary significantly with age, even though 
BMI has the largest relative risk in younger men. In 2003, Lakatta and his colleagues 
ascertained that the aging artery was a “set-up” for vascular diseases (Lakatta & Levy, 2003). 
In consideration of studies, both in aging animal models of IHD and censuses on clinical 
symptoms, it is now well acknowledged that age is a major independent risk factor for IHD 
although the mechanisms responsible for this age-related pathologic change remain implicit.  
2.2 Aging and IHD 
Aging, characterized by a progressive deterioration of organs and cells, play an imperative 
role in the manifestation of IHD. The incidence and prevalence of ischemic heart disease 
increases steeply with advancing age. Considerable evidence from animal studies and 
clinical observations indicates that aged hearts are more susceptible to I/R injury, suffer 
from greater infarct expansion, and exhibit poorer outcomes. It is also disappointing that 
therapies such as thrombolysis and preconditioning confer less benefit in the aged with 
myocardial infarction than in younger adults. With the “graying of the population,” the 
morbidity and mortality attributable to cardiovascular diseases will likely continue to 
increase, resulting in a significant increase in the already huge economic health care burden. 
These factors call for a multitude of our efforts in uncovering the mechanisms responsible 
for MI/R in aging patients.  
2.3 Possible mechanisms of high sensitivity to IHD in the elderly 
Aging is a complex phenomenon associated with changed DNA transcription and RNA 
translation together with protein expression. Ischemic heart disease results from severe 
impairment of the coronary blood supply usually produced by thrombosis or other acute 
alterations of coronary atherosclerotic plaques. A crucial early step of atherosclerosis is the 
binding to endothelial cells and subsequent subendothelial migration of circulating 
monocytes and their transformation into foam cells by the uptake of lipids. Intercellular 
adhesion molecule-1(ICAM-1) and vascular cell adhesion molecule-1(VCAM-1) in 
endothelial cells, mediating the adhesion of leukocytes, are suspected of playing an 
important role in the formulation of early atherosclerotic lesions. Nobuhiro Morisaki 
(Morisaki et al., 1997) found, through determining the two molecules soluble in serum, that 
sICAM-1 was correlated only to the presence of IHD but not to age; yet sVCAM-1, not 
sICAM-1, was positively correlated to age. In other words, age was the most powerful 
independent predictor of the level of sVCAM-1 and increased susceptibility to ischemia in 
some sense.  
What’s more, aging is considered as an energy deficit implicated in myocardial weakness 
and reduced functions in humans’ hearts. The deficit has been demonstrated to be related to 
the dysfunctional mitochondria that is responsible for the maximum output of ATP, 
working as a primary site of generation of Reactive Oxygen Species (ROS) and participating 
in the regulation of apoptosis. With growing age, in the cell and particularly in 
mitochondria, the defense capacities against ROS become insufficient. Excessive ROS attacks 
mRNA, DNA, and long-term proteins, which is especially obvious with aging.  
A decrease in the total number of myocytes is associated with heart damage and an 
accelerated decline in cardiac functional capacity observed in aging hearts (Zhang et al., 
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2003). It was commonly believed that cardiac myocytes had little ability to regenerate.  
Therefore, the cardiac function mainly relies on the survival of cardiomyocytes.  Two of the 
most common forms of cell death are programmed cell death and accidental cell death. 
Programmed cell death is characterized by a series of stereotypic morphological and 
biochemical features, which is easier to manipulate. It is reported that compared with 
necrosis, apoptosis is one of the major factors contributing to cardiomyocyte loss. An 
abundance of evidences certify that cytosolic cytochrome c content is sharply elevated in 
aging rats (Sharon et al., 2002). Furthermore, Bcl-2, an antiapoptotic protein shows a strong 
tendency to decrease with age, while Bax, a proapoptotic protein, remains unchanged, so do 
apoptotic protease-activating factor 1 levels and caspase-3 activities, regarded as executor 
caspases following caspase-8 or caspase-9 activation. Additionally, chronic oxidative stress 
with age induces the increase of manganese superoxide dismutase, glutathione peroxidase 
activity and lipid peroxidation in aging heart mitochondria, which may contribute to IHD. 
Therefore, age was a major independent risk factor for IHD, and cardiomyocyte death with 
age may be the last and main event of high sensitivity to IHD.  
3. Aging increases myocardial apoptosis under basal and stressed 
conditions  
Nowadays, our population is aging at an unprecedented rate, and during 2000-2030, the 
worldwide population aged >65 years is projected to increase by approximately 550 million 
to 973 million (U.S. Census Bureau), increasing from 6.9% to 12.0% worldwide (Kinsella & 
Velkoff, 2001). Data from numerous animal researches and clinical studies support that 
aging is a major independent risk factor in the markedly enhanced risk of cardiovascular 
diseases in the elderly. There are marked changes related to age in myocardial structure and 
function in both animals and humans. Previous studies have demonstrated that both 
diastolic and systolic functions were aggravated in senescent hearts. As the basis of cardiac 
function, cardiac structure has incurred numerous changes, such as enlarged cardiac 
myocyte size and reduced myocyte numbers in elderly hearts.  
3.1 Aging and myocardial apoptosis  
Numerous studies have demonstrated that there was a significant loss of cardiac myocytes 
constituting an important determinant of the aging process, possibly mediating the 
aggravation of cardiac function. In animal research models, there was around a 32.5% 
reduction of myocytes in the left ventricles of rats during a period of 4 to 29 months 
(Anversa et al., 1990). The study carried out on aging human hearts by G. Olivetti displayed 
that there was around 35% aggregate loss of myocytes in both ventricles for 70 year-old 
healthy men compared to 25 year-old healthy young adults (Olivetti et al., 1991). The factors 
responsible for the abnormal loss of the cells in the ventricles remain unclear, and it will 
possibly open a new field to prevent or even reverse the disappearance of cardiac myocytes 
of aged hearts to reveal the potential mechanism for the aging associated cell loss. 
Cell death may occur through active mechanisms like cellular suicide or active or 
programmed cell death, often referred to as apoptosis. Inactive mechanisms normally 
induced in acute situations by infarct, severe toxic chemicals and extreme thermal damage, 
normally conferred as necrosis. Many studies suggest that both apoptosis and necrosis are 
involved in the aging process (Ohshima, 2006). Apoptosis is more prevalent than necrosis in 
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senescent animals and humans and increased more significantly in old rats than in young 
adult ones after myocardial ischemia reperfusion (Liu et al., 2002). Different from necrosis, 
which is induced by injurious agents, apoptosis is an active programmed cell death 
characterized by a series of stereotypic morphological and biochemical features. Therefore, 
it is easier to inhibit apoptosis than to prohibit necrosis for the aging heart. 
3.2 Apoptosis with age and IHD 
Accumulating studies indicate that aging is associated with an increase in myocardial 
susceptibility to ischemia and a decrease in postischemic recovery of cardiac function. 
Zhang et al. reported that in aging rats, myocardial ischemia and reperfusion-induced 
cardiac injury was enhanced in aging mice as evidenced by enlarged infarct size (38.5±2.7% 
vs 52.0±1.8%) (Zhang et al, 2007). 
As stated above, myocardial apoptosis, a gene-regulated programmed cell death, markedly 
increases with aging. It has been determined that compared to young mice, myocardial 
ischemia and reperfusion in aging mice induced an increased apoptosis. Zhang investigated 
the detailed apoptotic cell death by TUNEL staining and caspase 3 activity assay, and found 
that TUNEL positive cells increased from 5.0±1.8% in young hearts to 8.8±0.9% in old ones, 
and that the caspase 3 activity increased from 18.0±0.9 nmol/h/mg protein to 27.4±1.9 
nmol/h/mg protein (Zhang et al, 2007). However, the molecular mechanisms and signaling 
transduction pathways that are responsible for increased susceptibility of cardiomyocytes to 
apoptosis with aging remain largely unidentified.  
3.3 Signal transduction pathways of apoptosis 
Accumulating evidence indicates that apoptosis is an active, gene-directed process. One of 
the most widely recognized biochemical features of apoptosis is the activation of a class of 
cysteine proteases known as caspases. Cells possess multiple caspases that may work in a 
cascade fashion. The redundancy may serve to amplify and accelerate the response, as well 
as provide multiple mechanisms for success. Three pathways that activate caspases have 
been identified: the first one is activated through a cell surface signal leading to caspase 8 
(and/or 10 in some cell types) activation; the second, more complicated pathway involves 
the mitochondria and results in caspase 9 activation; the third is activated via the 
endoplasmic reticulum and induces caspase 12 activation.  
A variety of cellular stresses have been found to cause the disruption and collapse of the 
inner mitochondrial transmembrane potential, thus opening  mitochondrial pores (termed 
“mitochondrial permeability transition" or MPT) and resulting in the release of cytochrome 
c. Cytochrome c released from the mitochondria activates caspase 9 in the presence of Apaf-
1 (apoptosis protease activating factor-1) and ATP. In some cell types, activation of caspase 8 
(and/or caspase 2) by the cell surface death receptor also increases mitochondrial 
cytochrome c release and subsequent caspase 9 activation by facilitating the translocation of 
full-length or truncated Bid (p15 Bid) from the cytosol to the mitochondrial membrane. As 
well known,  caspase 9 can also be activated by caspase 12 released from the endoplasmic 
reticulum (ER) under stress. The activation of caspases 8 and 9 (initiator) followed by 
caspase 3 (executor)(6, and 7 in some cell types) with subsequent  degradation of a variety of 
proteins results in irreversible damage of the cells (apoptotic cell death). Recent studies have 
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demonstrated that formation of MPT also results in mitochondrial release of AIF (apoptosis-
inducing factor), a molecule that directly results in apoptosis. 
Under physiologic conditions, apoptosis is regulated by the balance of a variety of pro- and 
anti-apoptotic molecules. The disturbance of these balances contributes to well-known 
pathologies, such as neurodegenerative diseases, ischemia/reperfusion injury and cancer. 
Specifically, the formation of MPT and subsequent release of cytochrome c and AIF are 
controlled by the balance between anti-apoptotic (e.g., Bcl-2, Bcl-xl, Bcl-w, Bag-1 and BI-1) 
and pro-apoptotic (e.g., Bax, Bak, Bad, Bid and Bim) Bcl-2 family members, which 
themselves are regulated by the balance of upstream regulators, such as extracellular signal-
regulated kinase 1/2 (ERK1/2) and Akt (anti-apoptotic), p38 mitogen-activated protein 
kinase (MAPK) and JNK (c-Jun N-terminal Kinase) (pro-apoptotic) at both transcriptional 
and post-transcriptional levels. In a recent study, Jiang and colleagues reported that 
activation of caspase 9 is positively regulated by tumor suppressor putative HLA-DR-
associated proteins (PHAP) but inhibited by oncoprotein prothymosin- (ProT)(Jiang et al, 
2003). Finally, the activation of caspase 3 is inhibited by IAP (inhibitor of apoptosis protein) 
and B-Crystallin, and promoted by Smac/DIABLO and Omi/HtrA2 (proteins that are also 
released from mitochondria under stress) by interaction with IAP. Given the extreme 
complexity of the apoptosis signal transduction and the exponentially-increasing number of 
pro- and anti-apoptotic molecules, it is highly unlikely that a specific cell type, i.e., 
cardiomyocytes, under specific stress, i.e., aging, will involve all of these apoptotic 
molecules and disturb every pro- and anti-apoptotic balance. Identifying the specific anti-
/pro-apoptotic balance(s) that is (are) disturbed by aging, and uncovering the mechanisms 
responsible for the deregulation of apoptotic cell death in the aging heart will be the critical 
first step toward prevention and treatment of apoptotic cell death in patients with any heart 
disease. In the next section we will identify the reactive nitrogen species (RNS) signal and 
HtrA2/Omi related mitochondrial apoptotic pathway disturbed in the aging heart. 
4. RNS signaling induced apoptosis contributes to increased susceptibility of 
aging hearts to myocardial ischemic Injury.  
4.1 An overview of reactive nitrogen species and pathway 
Considerable evidence suggests that reactive oxygen species (ROS) play critical roles in the 
aging process and post-ischemic myocardial apoptosis. However, the outcome of clinical 
trials with antioxidant treatment during MI/R has been rather disappointing, suggesting 
that other factors in addition to ROS exist. Most recent data have identified nitric oxide 
derived reactive nitrogen species (RNS) intermediates as critical contributors and cell injury.  
RNS are produced by the reaction of NO with superoxide (Carr et al., 2000) and include NO 
and its derivatives (Wu et al., 2007). NO, as the most important mediator of RNS, has been 
identified as having three categories of signaling pathways in controlling cell death: (1) 
Classical signaling involves the selective activation of soluble guanylate cyclase (sGC) 
(cGMP-dependent protein kinases) (2) Less classical signaling: NO binds to cytochrome c 
oxidase (CcO) in the mitochondria and its functional consequences (3) Nonclassical 
signaling alludes to the formation of NO-induced posttranslational modifications (PTMs), 
especially S-nitrosylation, S-glutathionylation, and tyrosine nitration(Antonio et al., 2011).   
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4.1.1 Nitric oxide signaling pathway - Classical signaling pathways and apoptosis 
In classical signaling pathways, NO induces the rupture of the His–Fe(II) bond within the 
heme of sGC, which catalyzes in the conversion of GTP to cGMP (Antonio et al., 2011). 
Effects of cGMP occur through three main groups of cellular targets: cGMP-dependent 
protein kinases (PKGs), cGMP-gated cation channels, and PDEs. cGMP binding activates 
PKG, which phosphorylates serines and threonines on many cellular proteins, frequently 
resulting in changes in activity or function, subcellular localization, or regulatory features 
(Francis et al., 2010). Accumulating data have showed NO could regulate apoptosis in 
classical signal pathways.  
4.1.1.1 cGMP-Dependent inhibition of apoptotic signal transduction 
Research has shown that NO protects against PC12 cell death by inhibiting the activation of 
caspase proteases through cGMP production and activation of protein kinase G (Kim et al., 
1999). Another work further proves that the NO/cGMP pathway suppresses 6-OHDA-
induced PC12 cell apoptosis by suppressing the mitochondrial apoptosis signal 
viaPKG/PI3K/Akt-dependent Bad phosphorylation (HA et al., 2003).  NO has also been 
shown to inhibit TNF-a-induced TRADD recruitment and caspase 8 activity in a cGMP-
dependent way (De Nadai et al., 2000). More direct data shows that over production of 
endogenous NO or supplementation with exogenous NO protects SK-N-BE human 
neuroblastoma againstapoptosis induced by serum deprivation by using cGMP as an 
intermediate effector (Ciani et al., 2002). The anti-apoptotic role of NO through cGMP is also 
revealed in hepatocytes (Calafell et al., 2009). In vivo data reveal that enhancing the 
NO/cGMP pathway reduces hypoxia-induced neuron apoptosis by upregulating the bcl-
2/Bax ratio (Caretti et al., 2008). NO has also been shown to antagonize estrogen induced 
apoptosis in breast epithelial cells (Kastrati et al., 2010). 
4.1.1.2 cGMP-Dependent induction of apoptotic signal transduction 
Despite evidence that NO is anti-apoptotic, data also show that NO can induce apoptosis in 
a cGMP dependent manner in isolated adult cardiomyocytes. Induction of apoptosis by 
SNAP in cardiomyocytes was blocked by inhibitors of caspase-3, soluble guanylyl cyclase 
(sGC) or of cGMP dependent protein kinase (PKG) (Taimor et al., 2000). In vascular cells NO 
is shown to induce apoptosis through cGMP-dependent Protein Kinase (PKG) (Chiche et al., 
1998). 
4.1.2 Nitric oxide signaling pathway - Less classical signaling pathways and 
apoptosis 
The critical mediator of NO regulating apoptosis in less classical signalling pathways is 
cytochrome c oxidase (CcO), which is located on the inner membrane of the mitochondrion 
and catalyzes the oxidation of cytochrome c and the reduction of oxygen to water (Taylor & 
Moncada, 2010). The enzyme belongs to the superfamily of heme-copper oxidases and 
contains a highly conserved bimetallic active site composed of the heme iron of cytochrome 
a3 and a copper ion, CuB. The binuclear center, in its reduced form, is the binding site of the 
physiological substrate, O2. NO closely resembles O2 and therefore can also bind to this site 
(Martinez-Ruiz et al., 2011). NO at low concentrations inhibits mitochondrial CcO, resulting 
in an increase in H2O2 in the mitochondria, and this excess of H2O2 activates the death 
signaling pathways (Yuyama et al., 2003). CcO potentially generates impairment of 
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mitochondrial function, which in turn may potentiate apoptotic commitment. The NO 
toxicity can be indicated by the decrease of cytochrome c oxidase activity, which is 
paralleled the extent of apoptosis (Ciriolo et al., 2000). 
4.1.3 Nitric oxide signaling pathway-nonclassical signaling pathways and apoptosis 
Nitric oxide could exert part of its effects not only in a cGMP independent manner, but also 
without the need of binding to other metal centers, through covalent posttranslational 
modification (PTM) of target proteins. This mode of action is defined as denominate 
nonclassical signaling and affects mainly cysteine and tyrosine residues in proteins. The 
three best known NO-induced posttranslational modifications are S-nitrosylation, S-
glutathionylation, and tyrosine nitration.  
4.1.3.1 S-nitrosylation and apoptosis 
S-nitrosylation is an important biological reaction of nitric oxide; it refers to the conversion 
of thiol groups, including cysteine residues in proteins, to form S-nitrosothiols. S-
Nitrosylation is a mechanism for dynamic, post-translational regulation of most classes of 
protein. NO has been shown to regulate apoptosis through S-nitrosylation of protein.  
Research hasrevealed that S-nitrosylation mainly antangonizes apoptosis by targeting many 
elements in both extrinsic and intrinsic pathways (Iyer et al., 2008). Fas, as a cell surface 
receptor, is a member of the tumor necrosis receptor superfamily that induces apoptosis 
when cross-linked by Fas ligand or by Fas agonist antibody (Park et al., 2006; Lavrik et al., 
2005; Mannick & Schonhoff, 2004). Regulation of cell signaling by protein nitrosylation is 
well exemplified in the Fas signalling pathway (Mannick & Schonhoff, 2004). Consistent 
with receptor-mediated apoptosis, two main pathways of Fas-mediated apoptosis have been 
identified (Park et al., 2006). In type1 cells caspase-8 directly cleaves caspase-3, which starts 
the death cascade. In type2 cells the quantity of caspase-8 is insufficient to directly activate 
the executioner caspase-3. Instead, it involves (activates) tBid- mediated cytochrome c (Cyto-
C) release from mitochondria followed by apoptosome formation (Park et al., 2006; Lavrik et 
al., 2005). In resting cells caspase-3 zymogens in mitochondria are kept inactive via S-
nitrosylation of their catalytic site cysteine. Caspase-3 may be S-nitrosylated in mitochondria 
due to an association between S-nitrosylated caspase-3 and NOS. Moreover, S-nitrosylated 
but not denitrosylated caspase-3 associates with acid sphingomyelinase (ASM) in 
mitochondria. The association of S-nitrosylated caspase-3 with ASM provides another level 
of apoptosis regulation by inhibiting capase-3 cleavage and activation by initiator caspases. 
When cells are stimulated by Fas ligand, caspase-3 becomes denitrosylated. Denitrosylation 
stimulates caspase-3 activity by two mechanisms. First, denitrosylation allows the catalytic 
site of caspase-3 to function. In addition, denitrosylated caspase-3 presumably dissociates 
from ASM, allowing initiator caspases to cleave caspase-3 to its fully active form. Thus S-
nitrosylation/denitrosylation serves as an off/on switch for caspase-3 function during 
apoptosis. Cyto-C activity is also regulated by nitrosylation during Fas-induced apoptosis. 
However, in contrast to caspase-3, Cyto-C is not nitrosylated in resting cells. Instead, when 
cells receive an apoptotic stimulus, Cyto-C is nitrosylated on its heme iron in mitochondria 
and then is rapidly released into the cytoplasm. In the cytoplasm, hemenitrosylated Cyto-C 
stimulates caspase-3 cleavage by the apoptosome. Thus, coordinated denitrosylation of 
caspase- 3 and hemenitrosylation of Cyto-C serves to enhance caspase activation and Fas-
induced apoptosis. It remains to be determined if denitrosylation of caspase-3 is directly 
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linked to nitrosylation of Cyto-C in mitochondria via a direct transfer of a NO+ group from 
the catalytic site cysteine of caspase-3 to the heme iron of Cyto-C (Mannick et al., 1997; 
Mannick & Schonhoff, 2004; Schonhoff et al., 2003; Stamler et al., 2001(Mannick et al., 1997; 
Mannick & Schonhoff, 2004; Schonhoff et al., 2003; Stamler et al., 2001). NO can also inhibit 
apoptosis by direct nitrosylation of caspase-9 ( Török et al., 2002). 
In intrinsic apoptosis pathways, Cyto-C is released from mitochondria into cytoplasm 
initiates the apoptotic signals (Brüne, 2003; Schonhoff et al., 2003) and has been suggested as 
the commitment step for apoptosis (Gaston et al., 2003). Previous studies suggest that 
nitrosylation of Cyto-C is a novel mechanism of apoptosis regulation in cells and a very 
early event in apoptotic signalling (Schonhoff et al., 2003). However, the critical commitment 
step in the mitochondrial pathway of apoptosis has not been firmly established. Several 
recent findings  suggest that caspase-9 activation is essential for, and likely represents, the 
commitment step for the mitochondrial pathway of apoptosis. Nitrosylation of caspase-9 by 
induced (i) NOS generated NO inhibits apoptosis downstream of Cyto-C release and would 
appear to be another mechanism negatively regulating this pathway of apoptosis (Török et 
al., 2002). Besides nitrosylation of caspases, another mechanism underlying the anti-
apoptotic effects of NO via S-nitrosylation includes stimulation of the anti-apoptotic activity 
(function) of thioredoxin (Trx), which depends on S-nitrosylation at Cys69 (Haendeler et al., 
2002). S-nitrosylation and inhibition of Apoptosis signal regulating kinase (ASK1) (in L929 
cells) at Cys869 also lead to anti-apoptosis (Park et al., 2004).   
Although most of the reports have proven that S-nitrosylation mainly inhibits apoptosis, 
there are also data showing that S-nitrosylation could induce apoptosis as well. The 
mechanisms underlying the pro-apoptotic effects of NO via S-nitrosylation include 
inhibition of the anti-apoptotic transcription factor NF-B through a variety of mechanisms, 
including S-nitrosylation of NF-B (in A549 cells) or nitrosylation of the target cysteine in 
the IB kinase complex (IKK) (in Jurkat cells) leading to decreased NF-B–mediated 
transcription and decreased Bcl-2 expression (Marshall & Stamler, 2002; Schonhoff et al., 
2006). p21ras, JNK kinase, and the p50 monomer (of p50-p65) have been identified as sites of 
S-nitrosylation that mediate the stimulation or inhibition of NF-B by NO (Marshall and 
Stamler, 2002).  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is S-nitrosylated by 
NO, which initiates an interaction with the E3 ligase Siah1, leading to nuclear translocation 
and ubiquitin-mediated degradation of nuclear target proteins (Benhar & Stamler, 2005). 
Hara et al. has demonstrated that deprenyl and TCH346 are neuroprotective by preventing 
the S-nitrosylation of GAPDH and inhibiting GAPDH/Siah cell death cascade (Hara et al., 
2006). NO can also enhance apoptosis by NO-induced persistent inhibition and nitrosylation 
of mitochondrial Cyto-C oxidase in lung endothelial cells (Zhang et al., 2005). The work 
done by Gu et al. has illustrated that S-Nitrosylation activated Matrix metalloproteinase-9 in 
vitro was implicated in the pathogenesis of neurodegenerative diseases, stroke, and induced 
neuronal apoptosis (Gu et al., 2002). 
4.1.3.2 S-Glutathionylation and apoptosis 
S-thiolation refers to the incorporation of a low-molecular-mass (LMM) thiol to a protein via 
formation of a mixed disulfide bridge between a cysteine residue and the LMM thiol. In the 
intracellular environment in which GSH is the major thiol present, its incorporation results 
in a PTM named S-glutathionylation or S-glutathiolation, or more commonly S-thiolation 
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(Martinez-Ruiz et al., 2011). Protein S-glutathiolation, the reversible covalent addition of 
glutathione to cysteine residues on target proteins, is emerging as a candidate mechanism 
by which both changes in the intracellular redox state and the generation of reactive oxygen 
and nitrogen species may be transduced into a functional response (Klatt & Lamas, 2000). S-
glutathionylation is a redox signaling mechanism that can be produced without the 
concourse of NO. However, evidence for S-glutathionylation induced by NO and/or RNS 
has accumulated, linking this modification with NO signalling (Giustarini et al., 2004). At 
least two mechanisms explain the link between RNS production and S-glutathionylation. 
One is the observed glutathionylation induced by peroxynitrite. The other is a nitrosylated 
protein cysteine may react with GSH, or S-nitrosoglutathione can be formed and react with 
the cysteine thiol, both leading to S-glutathionylation (Martinez-Ruiz et al., 2011).  
Vikas Anathy et al. demonstrated that stimulation with Fas ligand (FasL) induces S-
glutathionylation of Fas at cysteine 294 independently of nicotinamide adenine dinucleotide 
phosphate reduced oxidase – induced ROS. Instead, Fas is S-glutathionylated after caspase-
dependent degradation of Grx1, increasing subsequent caspase activation and apoptosis 
(Anathy et al., 2009). Suparna Qanungo et al. indicated S-glutathionylation of p65-NFκB as a 
major mechanism underlying the inhibition of the NF_B survival pathway and promotion of 
apoptosis after GSH supplementation in hypoxic pancreatic cancer cells (Qanungo et al., 
2007). Therefore, RNS could regulate apoptosis through S-glutathionylation of protein 
4.1.3.3 Tyrosine nitration and apoptosis  
RNS-mediated nitration modifications include nitration of tyrosine, tryptophan, amine, 
carboxylic acid, and phenylalanine groups. However, nitration of tyrosine residues to 
produce nitrotyrosine has recently received much attention. Protein tyrosine nitration is a 
covalent protein modification resulting from the addition of a nitro (-NO2) group onto one 
of the two equivalent ortho carbons of the aromatic ring of tyrosine residues (Gow et al., 
2004). Biological nitration of tyrosine depends largely on free radical chemistry. There are 
two main key nitration pathways that operate in vivo and involve peroxynitrite and 
hemoperoxidase-catalyzed nitration (Peluffo & Radi, 2007). Tyrosine nitration is a two-step 
process where the initial reaction is the oxidation of the aromatic ring of tyrosine to yield 
tyrosyl radical (Tyr) (oxidation step), which in turn adds NO2 (addition step) to yield 3-
NO2-Tyr (Peluffo & Radi, 2007). 
4.1.3.3.1 RNS-mediated Tyrosine nitration induction of Apoptotic Signal Transduction 
Work by Hortelano et al. indicates that nitric oxide-dependent apoptosis in macrophages 
occurs in the presence of a sustained increase of the mitochondrial transmembrane potential, 
and that the chemical modification and release of cytochrome c from the mitochondria 
precedes the changes of the mitochondrial transmembrane potential. NO-dependent 
apoptosis in macrophages involves a chemical modification of cytochrome c that alters its 
structure and facilitates release from the mitochondria, regardless of the changes of the 
mitochondrial transmembrane potential (Hortelano et al., 1999). Cassina et al. has shown 
that Tyr-67 is a preferential site of nitration among the four conserved tyrosine residues in 
cytochrome c. Cytochrome c3+ was more extensively nitrated than cytochrome c2+ by 
mitochondrial but also cytosolic or extracellular derived ONOO- diffusing to the 
intermembrane space (Cassina et al., 2000). Tao et al. proved that nitrative inactivation of 
Trx plays a proapoptotic role in postischemic myocardium (Tao et al., 2006). Studies 
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conducted by Li et al. demonstrated that there exists a TNF-ǂ-initiated, cardiomyocyte 
iNOS/NADPH oxidase-dependent, peroxynitrite-mediated signaling pathway that 
contributes to posttraumatic myocardial apoptosis. In this paper nitrotyrosine content acted 
as a footprint of in vivo peroxynitrite formation (Li et al., 2007). 
4.1.3.3.2 RNS-Mediated tyrosine nitration inhibition of apoptotic signal transduction 
Although many studies have shown that RNS-mediated tyrosine nitration mainly induce 
apoptosis. Some research indicated that it also can inhibit apoptosis. Work by Sonsoles 
Reinehr et al. indicates that CD95 nitration as a novel mechanism for apoptosis inhibition by 
NO, which competes with pro-apoptotic CD95-tyrosine phosphorylation(Reinehr et al,2004). 
The study of Nakagawa et al determined that cytochrome c nitrated by continuous 
treatment with peroxynitrite lost its ability to cause caspase cascade activation in vitro, 
whereas cytochrome c nitrated by a bolus peroxynitrite treatment had preserved activity 
(Nakagawa et al, 2007). 
Previous data have shown that Reactive Nitrogen Species can either stimulate (pro-
apoptosis) or prevent apoptosis (anti-apoptosis) (Boyd & Cadenas, 2002; Brüne, 2003; Choi 
et al., 2002; Patel et al., 1999). The concentrations and local environments including cellular 
redox state and the presence of free radicals of NO and RNS play a key role in determining 
whether they stimulate or inhibit apoptosis (Brüne, 2003). Peroxynitrite(ONOO-), an 
important RNS, is formed by the reaction between high concentrations of NO and 
superoxide . High concentrations of NO or ONOO-can induce apoptosis (Choi et al., 2002). 
Liang et al. demonstrated for the first time that L-arginine administered at different time 
points during I/R exerted different effects on post-ischemic myocardial injury and suggests 
that stimulation of eNOS reduces nitrative stress and decreases apoptosis whereas 
stimulation of iNOS increases nitrative stress and enhances myocardial reperfusion injury 
(Liang et al., 2004). But, Rus et al.’s results demonstrated that inhibition of iNOS raises the 
peroxidative and apoptotic level in the hypoxic heart indicating that this isoform may have 
a protective effect on this organ against hypoxia/reoxygenation injuries, and this challenges 
the conventional wisdom that iNOS is deleterious under these conditions (Rus et al., 2010). 
So, the effect on apoptosis of RNS and its regulation need further clarification. 
4.2 RNS signaling and aging myocardial ischemic injury 
Accumulated data have shown that nitric oxide derived reactive nitrogen intermediates are 
critical contributors in controlling apoptosis which determine the susceptibility of aging 
hearts to myocardial ischemic Injury. 
Gao et al’s results showed that the protective effects of adenosine on myocardial I/R injury 
are markedly diminished in aged animals and that the loss in NO release in response to 
adenosine may be at least partially responsible for this age-related alteration (Gao et al., 
2000). Studies also show that increased susceptibility of the type 2 diabetic GK rat heart to 
ischemic injury is not associated with impaired energy metabolism. Reduced coronary flow, 
upregulation of eNOS expression, and increased total NOx levels confirm NO pathway 
modifications in this model, presumably related to increased oxidative stress. Modifications 
in the NO pathway may play a major role in I/R injury of the type 2 diabetic GK rat heart 
(Desrois et al., 2010). Our results show that aging induces phenotypic upregulation of iNOS 
in the heart, in which ǃ-AR stimulation interacts with ischemia and triggers a markedly 
www.intechopen.com
 
Novel Strategies in Ischemic Heart Disease 440 
increased NO production, which creates a nitrative stress, generates toxic peroxynitrite, 
activates apoptosis, and eventually causes cardiac dysfunction and myocardial injury. An 
iNOS inhibitor-1400W can markedly attenuate these adverse effects in the aging heart  
(Li, 2006). 
4.3 Thioredoxin and aging-related myocardial apoptosis 
Thioredoxin (Trx) is a 12-kDa protein ubiquitously expressed in all living cells that fulfils a 
variety of biological functions related to cell proliferation and apoptosis. It is involved not 
only in cytoprotective functions against oxidative stress but also in the regulation of cellular 
proliferation and the aging process. Clinical and experimental results have demonstrated 
that inhibition of Trx promotes apoptosis (Lincoln et al, 2003). Recent in vitro studies 
demonstrate that Trx interacts directly with, and inhibits, the activity of apoptosis-
regulating kinase-1 (ASK1), a mitogen-activated protein (MAP) kinase that activates two 
proapoptotic kinases, p38 MAP kinase (MAPK) and c-Jun N-terminal kinase (JNK) (Liu & 
Min, 2002). In aged mouse livers, the ratio of ASK1/Trx–ASK1 (free ASK1/Trx-binding 
ASK1) increases and this correlates with the increased basal activity of the p38 MAPK 
pathway. These results suggest that Trx may play critical roles in cell proliferation and cell 
death in aging, and Trx activity/expression might be reduced in the aging heart, thus tilting 
the death/survival balance toward cell death and promoting ischemia/reperfusion injury.  
Under physiologic conditions, ASK1 activity is inhibited by several cellular factors, 
including Trx, glutaredoxin, and phosphoserine-binding protein 14-3-3 (Bishopric & 
Webster, 2002). Previous studies have demonstrated that many cellular stresses and 
apoptotic stimuli activate mitochondrial-dependent apoptotic pathways by facilitating 
dissociation of ASK1 with its inhibitory protein. Trx is physically associated with ASK1 in 
cardiac tissues from young animals. However, Trx–ASK1 binding was reduced in cardiac 
tissue from aging animals. Therefore, it is likely that increased posttranslational Trx 
modification in aging hearts results in disassociation of Trx from ASK1, thus increasing 
postischemic myocardial apoptosis by increasing p38 MAPK activity.  
Lots of studies have demonstrated that, in addition to upregulation or downregulation of 
Trx expression at the gene level, Trx activity is regulated by posttranslational modification. 
Three forms of posttranslational modification of Trx have been previously identified. These 
include oxidation, glutathionylation, and S-nitrosylation. Interestingly, all three forms of 
modification occur at cysteine residues but affect Trx function differently. Oxidation of the 
thiol groups of Cys-32 and-35 forms a disulfide bond which results in Trx inactivation. 
However, previous studies have demonstrated that administration of oxidized Trx-1 exerts 
significant antioxidant and cytoprotective effects unless intracellular Trx reductase is 
inhibited, indicating that oxidative Trx inhibition is reversible and this form of 
posttranslational modification may not be the major mechanism responsible for Trx 
inactivation in vivo (Andoh et al, 2003). Glutathionylation occurs at Cys-73, and this 
posttranslational modification significantly inhibits Trx activity (Casagrande et al, 2002). 
However, whether Trx glutathionylation may occur in vivo in diseased tissues remains 
completely unknown and the role of this form of posttranslational modification in 
regulating Trx function in vivo remains to be determined. S-nitrosylation has been reported 
to occur at either Cys-69 or Cys-73. In contrast to oxidation and glutathionylation, S-
nitrosylation increases Trx activity and further enhances its antiapoptotic effect (Haendeler 
et al., 2004; Mitchell & Marletta, 2005).  
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In a recent study, it has been demonstrated that, in addition to three previously reported 
posttranslational Trx modifications which all occur at the cysteine residue, Trx can also be 
modified at the tyrosine residue (protein nitration) in a peroxynitrite-dependent fashion 
(Tao et al., 2006). More interestingly, in contrast to the reversible (by Trx reductase) 
oxidative Trx inactivation, nitrative modification of Trx results in an irreversible 
inactivation. Therefore, nitric oxide and its secondary reaction products, particularly 
peroxynitrite, exert opposite effects on Trx activity. Specifically, nitric oxide itself induces 
Trx S-nitrosylation and enhances its activity. In contrast, peroxynitrite results in Trx 
nitration and causes an irreversible inactivation. In Zhang et al.’s study, Trx activity was 
determined by using the insulin disulfide reduction assay. Compared with young animals, 
cardiac Trx activity is decreased in the aging heart before myocardial ischemia and 
reperfusion, and this difference can be further amplified after myocardial ischemia and 
reperfusion. However, Trx expression is slightly increased, rather than decreased, in aging 
hearts. These results indicate that it is posttranslational Trx modification rather than 
reduced protein expression that reduces Trx activity in the aging heart (Zhang et al., 2007).  
5. A Mitochondrial pro-apoptotic protein, HtrA2/Omi, is another reason of 
enhanced MI/R injury in the aging heart  
It is well known that apoptotic cell death is orchestrated by a family of caspases. X-
chromosome linked inhibitor of apoptosis protein (XIAP), as a member of IAPs, was the 
most potent endogenous inhibitor of caspases in human beings. XIAP has three baculovirus 
IAP repeat (BIR1, BIR2, BIR3) domains and a really interesting new gene (RING) domain. 
Biochemical studies suggested BIR2 inhibits caspase-3 and caspase-7, whereas BIR3 inhibits 
caspase-9 (Deveraux et al., 1999). The RING domain is an E3 ligase that presumably directs 
targets to the ubiquitin-proteasome degradation system, such as caspase-3 (Salvesen & 
Duckett, 2002; Martin, 2002). The anti-apoptotic activity of XIAP is regulated by a group of 
proteins that bind to the BIR domains via N-terminal conserved 4-residue IAP-binding motif 
(Shi, 2002). Recently it has been shown that overexpression of XIAP via in vivo delivery in 
an adenovirus could reduce both myocardial apoptosis and infarction following I/R (Kim et 
al., 2011). Wang et al. the protein and mRNA content of XIAP in the heart after MI/R was 
decreased, while the protein content of XIAP showed positive correlation with cardiac 
function in 42 rats after MI/R(Wang et al., 2010). These findings suggested a link between 
myocardial apoptosis, and anti-apoptotic therapy was effective in reducing I/R injury. 
Meanwhile we found the degradation of XIAP in aging myocardium after MI/R was more 
than that in young myocardium after MI/R, which are consistent with previous results in 
which myocardial apoptosis was exaggerated with aging after MI/R. Additionally, the 
expression of XIAP was also significantly decreased than that in the young adult heart 
without the intervention of MI/R, which suggested that the decline of XIAP expression may 
be a major factor responsible for the increased susceptibility of the aging heart. 
XIAP is regulated by two cellular proteins, Smac/DIABLO and HtrA2/Omi, which are 
nuclear-encoded mitochondrial proteins. The cleavage of their mitochondrial-targeting 
sequences inside mitochondria generates processed active Smac /DIABLO and HtrA2/Omi 
with new apoptotic N termini, named the IAP-binding motif (IBM) (Srinivasula et al., 2003). 
Stimulated by apoptotic triggers, Smac/DIABLO and HtrA2/Omi release into the cytosol 
and competitively bind to the BIR domains of IAPs via IBM, so that the BIR-bound caspases 
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are released and reactivated, resulting in cell apoptosis (Wu et al., 2000, Suzuki et al., 2001). 
Unlike Smac/DIABLO, the pro-apoptotic activity of HtrA2/Omi involves not only IAP 
binding but also serine protease activity. Although Omi/HtrA2 and Smac/DIABLO both 
seem to target XIAP once released into the cytosol, increasing evidence suggests that 
Omi/HtrA2 may play a unique role in apoptosis. Several different Smac/DIABLO-deficient 
cells respond normally to various apoptotic stimuli, suggesting the existence of a redundant 
molecule or molecules compensating for a loss of Smac/DIABLO function (Okada et al., 
2002). In contrast, Omi/HtrA2-knockdown cells have shown to be more resistant to 
apoptotic stimuli (Martins et al., 2002). 
In addition, Liu et al. first provided direct evidence that a normal level of endogenously 
expressed HtrA2/Omi contributes to apoptosis after MI/R in vivo (Liu et al., 2005). Althaus 
et al. have also suggested that HtrA2/Omi plays a decisive role in apoptosis after MI/R in 
young rats (Althaus et al., 2007). Then Wang et al showed that the release of HtrA2/Omi 
from mitochondria to cytosol was significantly increased in the old MI/R rat heart 
compared with that in the young MI/R rats (Wang et al, 2006). Meanwhile, cytosol was 
markedly increased in the old sham group compared with that in the young sham group. 
Taken together, these results reveal that HtrA2/Omi plays a causative role in increased 
post-ischemic cardiomyocyte apoptosis in the aging heart (Okada et al., 2002). In order to 
investigate whether increased HtrA2/Omi plays an important role in aged myocardial 
apoptosis resulting in myocardial dysfunction and increased susceptibility to MI/R injury, 
Wang et al observed the effect of ucf-101, a highly selective Omi/HtrA2 inhibitor, on MI/R 
injury. They have provided direct evidence in the current study that treatment with ucf-101 
in aging MI/R animals reduced the caspase-3 activity and improved the cardiac functions. 
Their results demonstrated that translocation of Omi/HtrA2 from the mitochondria to the 
cytosol enhanced MI/R injury in aging heart via promoting myocardial apoptosis. These 
studies may provide some therapies to prevent the over-release of HtrA2/Omi from 
mitochondria with aging and reduce the risk for MI/R in the elderly. This could help to 
explain the loss of ventricular function with age and may lead to discoveries of specific 
therapeutic interventions that can attenuate this type of cell loss (Wang et al., 2010). 
6. Prospect 
Aging has become a major health issue and socioeconomic burden worldwide. Coronary 
heart disease is the leading cause of death worldwide, for patients presented with an acute 
myocardial infarction, early and successful myocardial reperfusion is the most effective 
interventional strategy for reducing infarct size and improving clinical outcomes. The 
process of myocardial reperfusion itself, however, can induce injury to the myocardium, 
thereby reducing the beneficial effects of myocardial reperfusion. Aging renders the heart 
more susceptible to cell death from ischemia/reperfusion. In order to develop strategies 
aimed to limit reversible and irreversible myocardial damage in older patients, there is a 
need to better understand how aging increases myocardial apoptosis in myocardial 
ischaemia/reperfusion.  
This chapter introduced that RNS signaling induced apoptosis contributes to increased 
susceptibility of aging hearts to myocardial ischemic injury, and the age-associated 
alterations in translocation of HtrA2/Omi from mitochondria to cytosol are implicated in 
the markedly increased risk for MI/R injury in old persons. 
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As mentioned above, three RNS signaling pathways have been recognized .On the one 
hand, many studies show that RNS can be pro-apoptotic; on the other hand, many studies 
show that RNS exert anti-apoptotic effects through the same signaling pathway. Further 
studies should continue to elucidate the many factors that determine how RNS promotes or 
inhibits apoptosis. 
Wang et al. results provide strong evidence that HtrA2/Omi plays a causative role in 
increased post-ischemic cardiomyocyte apoptosis in the aging heart, but the mechanisms of 
age-associated alterations in translocation of HtrA2/Omi from mitochondria to cytosol need 
elucidation. 
There is an urgent need for more research of myocardial ischemia/reperfusion conducted 
on senescent animals. Some researches about RNS signaling induced apoptosis contributes 
to increased susceptibility of aging hearts to myocardial ischemic injury have been 
performed in rats or mice. However, biological signaling pathways, proteolytic portfolios, 
and the overall response to myocardial injury can be quite different in these small rodents 
when compared to larger mammals. While these murine studies have provided invaluable 
insight and provoked new hypotheses, they must be carried forward using large animals 
that more closely recapitulate the clinically-relevant context and for carefully designed 
clinical trials involving aged human subjects. There also needs to be better coordinated 
efforts between basic science investigators, clinical trial managers and physicians. (Spinale, 
2010, as cited in Bujak et al., 2008; Singh et al., 2010; Lindsey, 2005; Juhaszova et al. ,2005 as 
cited in Bolli et al., 2004).  
Otherwise, most studies have been conducted on healthy aging animals. Ischemic heart 
disease develops as a consequence of a number of etiological risk factors and always coexists 
with other disease states. These include systemic arterial hypertension and related left 
ventricular hypertrophy, hyperlipidemia, and atherosclerosis, diabetes and insulin 
resistance, as well as heart failure. These systemic diseases with aging as a modifying 
condition exert multiple biochemical effects on the heart that can potentially affect the 
development of I/R injury and interfere with responses to cardioprotective interventions. 
Therefore, the development of rational therapeutic approaches to protect the ischemic heart 
requires preclinical studies that examine cardioprotection specifically in relation to 
complicating disease states and risk factors. Surprisingly, relatively little effort has been 
made to uncover the cellular mechanisms by which risk factors and systemic diseases such 
as hypertension, hyperlipidemia and atherosclerosis, diabetes, insulin resistance, and heart 
failure interfere with cardioprotective mechanisms of aging (Ferdinandy et al., 2007). 
Although, as mentioned above, RNS and HtrA2/Omi may be critical contributors in 
controlling apoptosis which determine the susceptibility of aging hearts to myocardial 
ischemic injury. 
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